Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
The vaccine had expired one month earlier; This non-serious case was reported by a consumer via call center representative and described the occurrence of expired vaccine used in a 45-year-old male patient who received HBV (Engerix B adult) (expiry date APR-2025) for prophylaxis. On 08-MAY-2025, the patient received the 3rd dose of Engerix B adult. On 08-MAY-2025, an unknown time after receiving Engerix B adult, the patient experienced expired vaccine used (Verbatim: The vaccine had expired one month earlier). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 19-MAY-2025 This report was submitted via the online direct entry reporting system. The reporter was the patient. The patient received his third Engerix-B adult dose and the vaccine had expired one month earlier, which led to expired vaccine used. The vaccinator did not provide him with the lot number and exact expiration date. The formulation was unknown. Doctor's office recommended the expired dose be repeated, but the patient has not yet decided if he would do this. Nothing else was reported. The patient/reporter did not provide lot number to the patient.